Found 13 matching trials
A Safety and Efficacy Study of Oral Cladribine in Subjects With Relapsing-remitting Multiple Sclerosis (RRMS)
PHASE3The purpose of the study is to determine if cladribine tablets are a safe a...
Location
Multiple Locations
Oral Cladribine B-cell Study
N/ATo study the impact of cladribine on peripheral and intrathecal B-cell, pla...
Location
Barts Health NHS Trust
Norwegian Study of Oral Cladribine and Rituximab in Multiple Sclerosis (NOR-MS)
PHASE3The main aim and overall objective of the study is to assess whether rituxi...
Location
Department of Neurology - Drammen, Vestre Viken HF
Safety and Efficacy of Cladribine Therapy After Anti CD20 Therapy
N/AProlonged anti CD20 therapy for the treatment of active multiple sclerosis ...
Location
Neurocenter of Southern Switzerland, Ospedale Regionale di Lugano
A Phase 2 Study of Cladribine Add-on to Interferon-beta (IFN-beta) Therapy in Multiple Sclerosis (MS) Subjects With Active Disease (ONWARD)
PHASE2The goal of this study was to evaluate the safety, tolerability and effecti...
Traditional Versus Early Aggressive Therapy for Multiple Sclerosis Trial
NAFDA-approved multiple sclerosis (MS) disease-modifying therapies (DMTs) tar...
Status
Active Not Recruiting
Location
University of Alabama at Birmingham
Treatments Being Tested
Natalizumab/natalizumab-sztn, Alemtuzumab, Ocrelizumab, Rituximab/rituximab-arrx/rituximab-abbs/rituximab-pvvr, Cladribine, Ofatumumab, Ublituximab-xiiy, Ocrelizumab and hyaluronidase-ocsqGlatiramer acetate, Interferons (intramuscular, subcutaneous, pegylated) Teriflunomide, Fumarates (dimethyl, diroximel, monomethyl) Fingolimod, Siponimod, Ozanimod, Ponesimod Effects of Oral Cladribine on Remyelination and Inflammation in Multiple Sclerosis Patients
PHASE4Multiple sclerosis (MS) is a chronic, immune-mediated, demyelinating diseas...
Location
Pontifical Catholic University of Rio Grande do Sul
GM-CLAG in Relapsed/Refractory FLT3-mutated AML
PHASE1The purpose of this study is to evaluate the dose-limiting toxicities (DLT)...
Location
University of Kentucky
Effects of Cladribine Tablets on the PK of Microgynon®
PHASE1The purpose of this study was to investigate the potential effects of cladr...
Location
St. Josef und St. Elisabeth Hospital gGmbH
CLARITY Extension Study
PHASE3The purpose of this extension trial was to further evaluate the safety and ...